Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, announced that its flagship product, Safety Shot, sold out within hours after being released on Amazon.com. The scientifically formulated beverage is the first patented beverage that helps consumers feel better faster by reducing blood alcohol content and boosting clarity. The announcement noted that the product was released on Amazon on Nov. 30, 2023, and without any introduction or announcement, Safety Shot sold out almost immediately. Amazon is the first direct-to-consumer platform to carry Safety Shot, which can also be purchased from the company’s website; the company also anticipates the product will be available in retail locations in first quarter 2024. A nutraceutical functional beverage, Safety Shot accelerates the body’s reduction and breakdown of alcohol while aiding in recovery and rehydration. “We’ve gone live with sales of Safety Shot on Amazon and demand is far higher than we initially expected,” said Safety Shot CEO Brian John in the press release. “We believe that this confirms that trying Safety Shot is believing in Safety Shot. We have given away thousands of cans now with the same response. They can’t believe how well it works and how good it makes you feel. We’re working diligently to increase production and inventory to meet anticipated demand.”
To view the full press release, visit https://ibn.fm/th4fq
About Safety Shot
Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. Safety Shot will be available for retail purchase in the first week of December 2023. The company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants and bars in the first quarter of 2024. Safety Shot plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders. For more information about the company, visit www.SafetyShotHoldings.com.
NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed)and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
